Evidence map›Paper›PMID 34991275›Full record

ReviewEpigenomes2019

The Relevance of Gender in Tumor-Influencing Epigenetic Traits.

Victoria Sarne, Sandrina Braunmueller, Lisa Rakob, Rita Seeboeck

Open access · diamondAbstract readReview
In one paragraph

Review in Epigenomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Sex and gender differences in cancer pathogenesis and pharmacology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Victoria SarneDepartment Life Sciences, IMC University of Applied Sciences Krems, 3500 Krems an der Donau, Austria.ORCID 0000-0003-1053-4033
Sandrina BraunmuellerDepartment Life Sciences, IMC University of Applied Sciences Krems, 3500 Krems an der Donau, Austria.
Lisa RakobDepartment Life Sciences, IMC University of Applied Sciences Krems, 3500 Krems an der Donau, Austria.
Rita SeeboeckDepartment Life Sciences, IMC University of Applied Sciences Krems, 3500 Krems an der Donau, Austria.ORCID 0000-0003-3169-7843
IMC University of Applied Sciences Krems · AT

Funding

Österreichische Forschungsförderungsgesellschaft 849800
6 · The paper itself

Abstract

Tumorigenesis as well as the molecular orchestration of cancer progression are very complex mechanisms that comprise numerous elements of influence and regulation. Today, many of the major concepts are well described and a basic understanding of a tumor's fine-tuning is given. Throughout the last decade epigenetics has been featured in cancer research and it is now clear that the underlying mechanisms, especially DNA and histone modifications, are important regulators of carcinogenesis and tumor progression. Another key regulator, which is well known but has been neglected in scientific approaches as well as molecular diagnostics and, consequently, treatment conceptualization for a long time, is the subtle influence patient gender has on molecular processes. Naturally, this is greatly based on hormonal differences, but from an epigenetic point of view, the diverse susceptibility to stress and environmental influences is of prime interest. In this review we present the current view on which and how epigenetic modifications, emphasizing DNA methylation, regulate various tumor diseases. It is our aim to elucidate gender and epigenetics and their interconnectedness, which will contribute to understanding of the prospect molecular orchestration of cancer in individual tumors.

Indexed as

carcinogenesisDNA methylationepigeneticsgender medicineprecision medicinesextumor marker

Identifiers

PMID34991275
PMCPMC8594720
OpenAlexW2913696609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.